Health technology assessment : HTA
-
Health Technol Assess · Nov 2018
Meta AnalysisLow-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Diagnosis of lung cancer frequently occurs in its later stages. Low-dose computed tomography (LDCT) could detect lung cancer early. ⋯ The National Institute for Health Research Health Technology Assessment programme.
-
Health Technol Assess · Nov 2018
Brain and spinal stimulation therapies for phantom limb pain: a systematic review.
Although many treatments exist for phantom limb pain (PLP), the evidence supporting them is limited and there are no guidelines for PLP management. Brain and spinal cord neurostimulation therapies are targeted at patients with chronic PLP but have yet to be systematically reviewed. ⋯ The National Institute for Health Research Health Technology Assessment programme.
-
Health Technol Assess · Sep 2018
Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
Neuroendocrine tumours (NETs) are a group of heterogeneous cancers that develop in cells in the diffuse neuroendocrine system. ⋯ The National Institute for Health Research Health Technology Assessment programme.
-
Health Technol Assess · May 2018
What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis.
Diabetic retinopathy screening (DRS) is effective but uptake is suboptimal. ⋯ The National Institute for Health Research Health Technology Assessment programme.
-
Health Technol Assess · Jan 2018
Review Meta AnalysisAxitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation.
Several therapies have recently been approved for use in the NHS for pretreated advanced or metastatic renal cell carcinoma (amRCC), but there is a lack of comparative evidence to guide decisions between them. ⋯ The National Institute for Health Research Health Technology Assessment programme.